Publication | Closed Access

Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration

InflammationAutoimmune DiseaseInflammatory Cell MigrationBlood–brain BarrierMedicineImmunologyExperimental Autoimmune EncephalomyelitisBlood-brain BarrierAutoimmunityBrain-immune InteractionNeuroprotectionNeurologyImmunologic DiseaseImmunotherapyNeuroimmunologyNeuroinflammation